Osteosarcoma in Korean children and adolescents.
10.3345/kjp.2015.58.4.123
- Author:
Jun Ah LEE
1
Author Information
1. Department of Pediatrics, Korea Cancer Center Hospital, Seoul, Korea. junahlee@kcch.re.kr
- Publication Type:Review
- Keywords:
Osteosarcoma;
Korea;
Child;
Adolescents
- MeSH:
Adolescent*;
Child*;
Disease-Free Survival;
Drug Therapy, Combination;
Humans;
Korea;
Osteosarcoma*
- From:Korean Journal of Pediatrics
2015;58(4):123-128
- CountryRepublic of Korea
- Language:English
-
Abstract:
Osteosarcoma is the most frequent primary bone tumor. Advances in combination chemotherapy and surgical technique have greatly improved the survival of patients with osteosarcoma. In Korea, improvements in osteosarcoma treatment have been made over the past two decades. The 5-year event-free survival rate of Korean children and adolescents with localized disease is 64.6%, comparable to that of American or European patients. This article provides an overview of current therapies for osteosarcoma in Korea.
